{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:26:57Z","timestamp":1786508817976,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS084959"],"award-info":[{"award-number":["R01 NS084959"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS084959"],"award-info":[{"award-number":["R01 NS084959"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS084959"],"award-info":[{"award-number":["R01 NS084959"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dravet syndrome is a developmental and epileptic encephalopathy (DEE) characterized by intractable seizures, comorbidities related to developmental, cognitive, and motor delays, and a high mortality burden due to sudden unexpected death in epilepsy (SUDEP). Most Dravet syndrome cases are attributed to\n                    <jats:italic>SCN1A<\/jats:italic>\n                    haploinsufficiency, with genetic modifiers and environmental factors influencing disease severity. Mouse models with heterozygous deletion of\n                    <jats:italic>Scn1a<\/jats:italic>\n                    recapitulate key features of Dravet syndrome, including seizures and premature mortality; however, severity varies depending on genetic background. Here, we refined two Dravet survival modifier (\n                    <jats:italic>Dsm<\/jats:italic>\n                    ) loci,\n                    <jats:italic>Dsm2<\/jats:italic>\n                    on chromosome 7 and\n                    <jats:italic>Dsm3<\/jats:italic>\n                    on chromosome 8, using interval-specific congenic (ISC) mapping.\n                    <jats:italic>Dsm2<\/jats:italic>\n                    was complex and encompassed at least two separate loci, while\n                    <jats:italic>Dsm3<\/jats:italic>\n                    was refined to a single locus. Candidate modifier genes within these refined loci were prioritized based on brain expression, strain-dependent differences, and biological relevance to seizures or epilepsy. High priority candidate genes for\n                    <jats:italic>Dsm2<\/jats:italic>\n                    include\n                    <jats:italic>Nav2<\/jats:italic>\n                    ,\n                    <jats:italic>Ptpn5<\/jats:italic>\n                    ,\n                    <jats:italic>Ldha<\/jats:italic>\n                    ,\n                    <jats:italic>Dbx1<\/jats:italic>\n                    ,\n                    <jats:italic>Prmt3<\/jats:italic>\n                    and\n                    <jats:italic>Slc6a5<\/jats:italic>\n                    , while\n                    <jats:italic>Dsm3<\/jats:italic>\n                    has a single high priority candidate,\n                    <jats:italic>Psd3<\/jats:italic>\n                    . This study underscores the complex genetic architecture underlying Dravet syndrome and provides insights into potential modifier genes that could influence disease severity and serve as novel therapeutic targets.\n                  <\/jats:p>","DOI":"10.1007\/s00335-024-10046-3","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T14:02:14Z","timestamp":1718114534000},"page":"334-345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8"],"prefix":"10.1007","volume":"35","author":[{"given":"Nicole A.","family":"Hawkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Speakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1726-4769","authenticated-orcid":false,"given":"Jennifer A.","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"10046_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s12311-022-01379-3","volume":"22","author":"A Accogli","year":"2023","unstructured":"Accogli A, Lu S, Musante I, Scudieri P, Rosenfeld JA, Severino M, Baldassari S, Iacomino M, Riva A, Balagura G, Piccolo G, Minetti C, Roberto D, Xia F, Razak R, Lawrence E, Hussein M, Chang EY, Holick M, Cal\u00ec E, Aliberto E, De-Sarro R, Gambardella A, UD Network, SS Group, Emrick L, McCaffery PJA, Clagett-Dame M, Marcogliese PC, Bellen HJ, Lalani SR, Zara F, Striano P, Salpietro V (2023) Loss of neuron navigator 2 impairs brain and cerebellar development. Cerebellum 22:206\u2013222","journal-title":"Cerebellum"},{"key":"10046_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248\u2013249","journal-title":"Nat Methods"},{"key":"10046_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2017.97","volume":"4","author":"VT Akins","year":"2017","unstructured":"Akins VT, Weragalaarachchi K, Picardo MCD, Revill AL, Del Negro CA (2017) Morphology of Dbx1 respiratory neurons in the preB\u00f6tzinger complex and reticular formation of neonatal mice. Sci Data 4:170097","journal-title":"Sci Data"},{"key":"10046_CR4","doi-asserted-by":"publisher","first-page":"15363","DOI":"10.1074\/jbc.M114.562785","volume":"289","author":"JH Baek","year":"2014","unstructured":"Baek JH, Rubinstein M, Scheuer T, Trimmer JS (2014) Reciprocal changes in phosphorylation and methylation of mammalian brain sodium channels in response to seizures. J Biol Chem 289:15363\u201315373","journal-title":"J Biol Chem"},{"key":"10046_CR5","doi-asserted-by":"publisher","first-page":"D924","DOI":"10.1093\/nar\/gkaa914","volume":"49","author":"RM Baldarelli","year":"2021","unstructured":"Baldarelli RM, Smith CM, Finger JH, Hayamizu TF, McCright IJ, Xu J, Shaw DR, Beal JS, Blodgett O, Campbell J, Corbani LE, Frost PJ, Giannatto SC, Miers DB, Kadin JA, Richardson JE, Ringwald M (2021) The mouse gene expression database (GXD): 2021 update. Nucleic Acids Res 49:D924-d931","journal-title":"Nucleic Acids Res"},{"key":"10046_CR6","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1016\/j.febslet.2013.07.043","volume":"587","author":"P Beltran-Alvarez","year":"2013","unstructured":"Beltran-Alvarez P, Espejo A, Schmauder R, Beltran C, Mrowka R, Linke T, Batlle M, P\u00e9rez-Villa F, P\u00e9rez GJ, Scornik FS, Benndorf K, Pagans S, Zimmer T, Brugada R (2013) Protein arginine methyl transferases-3 and -5 increase cell surface expression of cardiac sodium channel. FEBS Lett 587:3159\u20133165","journal-title":"FEBS Lett"},{"key":"10046_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol) 57:289\u2013300","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"10046_CR8","doi-asserted-by":"publisher","first-page":"7498","DOI":"10.1038\/s41380-021-01281-0","volume":"26","author":"B Brant","year":"2021","unstructured":"Brant B, Stern T, Shekhidem HA, Mizrahi L, Rosh I, Stern Y, Ofer P, Asleh A, Umanah GKE, Jada R, Levy NS, Levy AP, Stern S (2021) IQSEC2 mutation associated with epilepsy, intellectual disability, and autism results in hyperexcitability of patient-derived neurons and deficient synaptic transmission. Mol Psychiatry 26:7498\u20137508","journal-title":"Mol Psychiatry"},{"key":"10046_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1528-1167.2010.02912.x","volume":"52","author":"SW Briggs","year":"2011","unstructured":"Briggs SW, Walker J, Asik K, Lombroso P, Naegele J, Aaron G (2011) STEP regulation of seizure thresholds in the hippocampus. Epilepsia 52:497\u2013506","journal-title":"Epilepsia"},{"key":"10046_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuropharm.2017.09.026","volume":"128","author":"M Chatterjee","year":"2018","unstructured":"Chatterjee M, Kurup PK, Lundbye CJ, Hugger Toft AK, Kwon J, Benedict J, Kamceva M, Banke TG, Lombroso PJ (2018) STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice. Neuropharmacology 128:43\u201353","journal-title":"Neuropharmacology"},{"key":"10046_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, le Wang L, Coon M, Nguyen T, Wang L, Land SJ, Lu X, Ruden DM (2012) A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (austin) 6:80\u201392","journal-title":"Fly (austin)"},{"key":"10046_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eplepsyres.2016.10.006","volume":"128","author":"MS Cooper","year":"2016","unstructured":"Cooper MS, McIntosh A, Crompton DE, McMahon JM, Schneider A, Farrell K, Ganesan V, Gill D, Kivity S, Lerman-Sagie T, McLellan A, Pelekanos J, Ramesh V, Sadleir L, Wirrell E, Scheffer IE (2016) Mortality in Dravet syndrome. Epilepsy Res 128:43\u201347","journal-title":"Epilepsy Res"},{"issue":"Suppl 3","key":"10046_CR13","first-page":"S49","volume":"60","author":"F Darra","year":"2019","unstructured":"Darra F, Battaglia D, Dravet C, Patrini M, Offredi F, Chieffo D, Piazza E, Fontana E, Olivieri G, Turrini I, DallaBernardina B, Granata T, Ragona F (2019) Dravet syndrome: early electroclinical findings and long-term outcome in adolescents and adults. Epilepsia 60(Suppl 3):S49-s58","journal-title":"Epilepsia"},{"key":"10046_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1103","volume":"8","author":"IM de Lange","year":"2020","unstructured":"de Lange IM, Mulder F, van\u2019t Slot R, Sonsma ACM, van Kempen MJA, Nijman IJ, Ernst RF, Knoers N, Brilstra EH, Koeleman BPC (2020) Modifier genes in SCN1A-related epilepsy syndromes. Mol Genet Genomic Med 8:e1103","journal-title":"Mol Genet Genomic Med"},{"key":"10046_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/jmg.2008.062323","volume":"46","author":"C Depienne","year":"2009","unstructured":"Depienne C, Trouillard O, Saint-Martin C, Gourfinkel-An I, Bouteiller D, Carpentier W, Keren B, Abert B, Gautier A, Baulac S, Arzimanoglou A, Cazeneuve C, Nabbout R, LeGuern E (2009) Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet 46:183\u2013191","journal-title":"J Med Genet"},{"key":"10046_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/jmg.2009.074328","volume":"47","author":"C Depienne","year":"2010","unstructured":"Depienne C, Trouillard O, Gourfinkel-An I, Saint-Martin C, Bouteiller D, Graber D, Barthez-Carpentier MA, Gautier A, Villeneuve N, Dravet C, Livet MO, Rivier-Ringenbach C, Adam C, Dupont S, Baulac S, H\u00e9ron D, Nabbout R, Leguern E (2010) Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome. J Med Genet 47:404\u2013410","journal-title":"J Med Genet"},{"issue":"Suppl 2","key":"10046_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","volume":"52","author":"C Dravet","year":"2011","unstructured":"Dravet C (2011) The core Dravet syndrome phenotype. Epilepsia 52(Suppl 2):3\u20139","journal-title":"Epilepsia"},{"key":"10046_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/B978-0-444-52891-9.00065-8","volume":"111","author":"C Dravet","year":"2013","unstructured":"Dravet C, Oguni H (2013) Dravet syndrome (severe myoclonic epilepsy in infancy). Handb Clin Neurol 111:627\u2013633","journal-title":"Handb Clin Neurol"},{"key":"10046_CR19","first-page":"71","volume":"95","author":"C Dravet","year":"2005","unstructured":"Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O (2005) Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 95:71\u2013102","journal-title":"Adv Neurol"},{"issue":"1","key":"10046_CR20","doi-asserted-by":"publisher","first-page":"fcae004","DOI":"10.1093\/braincomms\/fcae004","volume":"6","author":"T Feng","year":"2024","unstructured":"Feng T, Makiello P, Dunwoody B, Steckler F, Symonds JD, Zuberi SM, Dorris L, Brunklaus A (2024) Long-term predictors of developmental outcome and disease burden in SCN1A-positive Dravet syndrome. Brain Commun 6(1):fcae004","journal-title":"Brain Commun"},{"issue":"4","key":"10046_CR21","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/epi.17882","volume":"65","author":"D Gallagher","year":"2024","unstructured":"Gallagher D, P\u00e9rez-Palma E, Bruenger T, Ghanty I, Brilstra E, Ceulemans B, Chemaly N, de Lange I, Depienne C, Guerrini R, Mei D, M\u00f8ller RS, Nabbout R, Regan BM, Schneider AL, Scheffer IE, Schoonjans AS, Symonds JD, Weckhuysen S, Zuberi SM, Lal D, Brunklaus A (2024) Genotype-phenotype associations in 1018 individuals with SCN1A-related epilepsies. Epilepsia 65(4):1046\u20131059","journal-title":"Epilepsia"},{"key":"10046_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109513","volume":"231","author":"AG George","year":"2023","unstructured":"George AG, Farrell JS, Colangeli R, Wall AK, Gom RC, Kesler MT, Rodriguez de la Hoz C, Villa BR, Perera T, Rho JM, Kurrasch D, Teskey GC (2023) Sudden unexpected death in epilepsy is prevented by blocking postictal hypoxia. Neuropharmacology 231:109513","journal-title":"Neuropharmacology"},{"key":"10046_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/0883073813509016","volume":"29","author":"H Goldberg-Stern","year":"2014","unstructured":"Goldberg-Stern H, Aharoni S, Afawi Z, Bennett O, Appenzeller S, Pendziwiat M, Kuhlenb\u00e4umer G, Basel-Vanagaite L, Shuper A, Korczyn AD, Helbig I (2014) Broad phenotypic heterogeneity due to a novel SCN1A mutation in a family with genetic epilepsy with febrile seizures plus. J Child Neurol 29:221\u2013226","journal-title":"J Child Neurol"},{"key":"10046_CR24","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1111\/j.1528-1167.2010.02790.x","volume":"51","author":"R Guerrini","year":"2010","unstructured":"Guerrini R, Cellini E, Mei D, Metitieri T, Petrelli C, Pucatti D, Marini C, Zamponi N (2010) Variable epilepsy phenotypes associated with a familial intragenic deletion of the SCN1A gene. Epilepsia 51:2474\u20132477","journal-title":"Epilepsia"},{"key":"10046_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180485","volume":"12","author":"MF Hammer","year":"2017","unstructured":"Hammer MF, Ishii A, Johnstone L, Tchourbanov A, Lau B, Sprissler R, Hallmark B, Zhang M, Zhou J, Watkins J, Hirose S (2017) Rare variants of small effect size in neuronal excitability genes influence clinical outcome in Japanese cases of SCN1A truncation-positive Dravet syndrome. PLoS ONE 12:e0180485","journal-title":"PLoS ONE"},{"key":"10046_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006398","volume":"12","author":"NA Hawkins","year":"2016","unstructured":"Hawkins NA, Zachwieja NJ, Miller AR, Anderson LL, Kearney JA (2016) Fine mapping of a Dravet syndrome modifier locus on mouse chromosome 5 and candidate gene analysis by RNA-seq. PLoS Genet 12:e1006398","journal-title":"PLoS Genet"},{"key":"10046_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.expneurol.2018.10.010","volume":"311","author":"NA Hawkins","year":"2019","unstructured":"Hawkins NA, Calhoun JD, Huffman AM, Kearney JA (2019) Gene expression profiling in a mouse model of Dravet syndrome. Exp Neurol 311:247\u2013256","journal-title":"Exp Neurol"},{"key":"10046_CR28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00335-021-09877-1","volume":"32","author":"NA Hawkins","year":"2021","unstructured":"Hawkins NA, Nomura T, Duarte S, Barse L, Williams RW, Homanics GE, Mulligan MK, Contractor A, Kearney JA (2021) Gabra2 is a genetic modifier of Dravet syndrome in mice. Mamm Genome 32:350\u2013363","journal-title":"Mamm Genome"},{"key":"10046_CR29","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1172\/JCI66220","volume":"123","author":"F Kalume","year":"2013","unstructured":"Kalume F, Westenbroek RE, Cheah CS, Yu FH, Oakley JC, Scheuer T, Catterall WA (2013) Sudden unexpected death in a mouse model of Dravet syndrome. J Clin Invest 123:1798\u20131808","journal-title":"J Clin Invest"},{"key":"10046_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.gde.2010.12.007","volume":"21","author":"JA Kearney","year":"2011","unstructured":"Kearney JA (2011) Genetic modifiers of neurological disease. Curr Opin Genet Dev 21:349\u2013353","journal-title":"Curr Opin Genet Dev"},{"key":"10046_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00335-022-09955-y","volume":"33","author":"JA Kearney","year":"2022","unstructured":"Kearney JA, Copeland-Hardin LD, Duarte S, Zachwieja NA, Eckart-Frank IK, Hawkins NA (2022) Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11. Mamm Genome 33:565\u2013574","journal-title":"Mamm Genome"},{"key":"10046_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13041-019-0543-3","volume":"13","author":"H Kim","year":"2020","unstructured":"Kim H, Jung H, Jung H, Kwon SK, Ko J, Um JW (2020) The small GTPase ARF6 regulates GABAergic synapse development. Mol Brain 13:2","journal-title":"Mol Brain"},{"key":"10046_CR33","doi-asserted-by":"publisher","first-page":"D933","DOI":"10.1093\/nar\/gkac958","volume":"51","author":"FJ Martin","year":"2023","unstructured":"Martin FJ, Amode MR, Aneja A, Austine-Orimoloye O, Azov AG, Barnes I, Becker A, Bennett R, Berry A, Bhai J, Bhurji SK, Bignell A, Boddu S, BrancoLins PR, Brooks L, Ramaraju SB, Charkhchi M, Cockburn A, Da Rin FL, Davidson C, Dodiya K, Donaldson S, El Houdaigui B, El Naboulsi T, Fatima R, Giron CG, Genez T, Ghattaoraya GS, Martinez JG, Guijarro C, Hardy M, Hollis Z, Hourlier T, Hunt T, Kay M, Kaykala V, Le T, Lemos D, Marques-Coelho D, Marug\u00e1n JC, Merino GA, Mirabueno LP, Mushtaq A, Hossain SN, Ogeh DN, Sakthivel MP, Parker A, Perry M, Pili\u017eota I, Prosovetskaia I, P\u00e9rez-Silva JG, Salam AIA, Saraiva-Agostinho N, Schuilenburg H, Sheppard D, Sinha S, Sipos B, Stark W, Steed E, Sukumaran R, Sumathipala D, Suner MM, Surapaneni L, Sutinen K, Szpak M, Tricomi FF, Urbina-G\u00f3mez D, Veidenberg A, Walsh TA, Walts B, Wass E, Willhoft N, Allen J, Alvarez-Jarreta J, Chakiachvili M, Flint B, Giorgetti S, Haggerty L, Ilsley GR, Loveland JE, Moore B, Mudge JM, Tate J, Thybert D, Trevanion SJ, Winterbottom A, Frankish A, Hunt SE, Ruffier M, Cunningham F, Dyer S, Finn RD, Howe KL, Harrison PW, Yates AD, Flicek P (2023) Ensembl 2023. Nucleic Acids Res 51:D933-d941","journal-title":"Nucleic Acids Res"},{"key":"10046_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, Flicek P, Cunningham F (2016) The ensembl variant effect predictor. Genome Biol 17:122","journal-title":"Genome Biol"},{"key":"10046_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ydbio.2011.03.008","volume":"353","author":"EM McNeill","year":"2011","unstructured":"McNeill EM, Kl\u00f6ckner-Bormann M, Roesler EC, Talton LE, Moechars D, Clagett-Dame M (2011) Nav2 hypomorphic mutant mice are ataxic and exhibit abnormalities in cerebellar development. Dev Biol 353:331\u2013343","journal-title":"Dev Biol"},{"key":"10046_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105423","volume":"157","author":"N Miljanovic","year":"2021","unstructured":"Miljanovic N, Hauck SM, van Dijk RM, Di Liberto V, Rezaei A, Potschka H (2021) Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model. Neurobiol Dis 157:105423","journal-title":"Neurobiol Dis"},{"key":"10046_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/gbb.12099","volume":"13","author":"AR Miller","year":"2014","unstructured":"Miller AR, Hawkins NA, McCollom CE, Kearney JA (2014) Mapping genetic modifiers of survival in a mouse model of Dravet syndrome. Genes Brain Behav 13:163\u2013172","journal-title":"Genes Brain Behav"},{"key":"10046_CR38","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/hmg\/7.10.1599","volume":"7","author":"IM Morison","year":"1998","unstructured":"Morison IM, Reeve AE (1998) A catalogue of imprinted genes and parent-of-origin effects in humans and animals. Hum Mol Genet 7:1599\u20131609","journal-title":"Hum Mol Genet"},{"key":"10046_CR39","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1212\/01.WNL.0000069463.41870.2F","volume":"60","author":"R Nabbout","year":"2003","unstructured":"Nabbout R, Gennaro E, DallaBernardina B, Dulac O, Madia F, Bertini E, Capovilla G, Chiron C, Cristofori G, Elia M, Fontana E, Gaggero R, Granata T, Guerrini R, Loi M, La Selva L, Lispi ML, Matricardi A, Romeo A, Tzolas V, Valseriati D, Veggiotti P, Vigevano F, Vall\u00e9e L, DagnaBricarelli F, Bianchi A, Zara F (2003) Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology 60:1961\u20131967","journal-title":"Neurology"},{"key":"10046_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/hum.2019.225","volume":"31","author":"Y Niibori","year":"2020","unstructured":"Niibori Y, Lee SJ, Minassian BA, Hampson DR (2020) Sexually divergent mortality and partial phenotypic rescue after gene therapy in a mouse model of Dravet syndrome. Hum Gene Ther 31:339\u2013351","journal-title":"Hum Gene Ther"},{"key":"10046_CR41","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1113\/JP277651","volume":"597","author":"T Nomura","year":"2019","unstructured":"Nomura T, Hawkins NA, Kearney JA, George AL Jr, Contractor A (2019) Potentiating \u03b1(2) subunit containing perisomatic GABA(A) receptors protects against seizures in a mouse model of Dravet syndrome. J Physiol 597:4293\u20134307","journal-title":"J Physiol"},{"key":"10046_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev-physiol-021014-071846","volume":"77","author":"HA O\u2019Malley","year":"2015","unstructured":"O\u2019Malley HA, Isom LL (2015) Sodium channel \u03b2 subunits: emerging targets in channelopathies. Annu Rev Physiol 77:481\u2013504","journal-title":"Annu Rev Physiol"},{"key":"10046_CR43","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.1523\/JNEUROSCI.5270-06.2007","volume":"27","author":"I Ogiwara","year":"2007","unstructured":"Ogiwara I, Miyamoto H, Morita N, Atapour N, Mazaki E, Inoue I, Takeuchi T, Itohara S, Yanagawa Y, Obata K, Furuichi T, Hensch TK, Yamakawa K (2007) Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 27:5903\u20135914","journal-title":"J Neurosci"},{"key":"10046_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.eplepsyres.2007.03.018","volume":"75","author":"H Osaka","year":"2007","unstructured":"Osaka H, Ogiwara I, Mazaki E, Okamura N, Yamashita S, Iai M, Yamada M, Kurosawa K, Iwamoto H, Yasui-Furukori N, Kaneko S, Fujiwara T, Inoue Y, Yamakawa K (2007) Patients with a sodium channel alpha 1 gene mutation show wide phenotypic variation. Epilepsy Res 75:46\u201351","journal-title":"Epilepsy Res"},{"issue":"1","key":"10046_CR45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjos-2018-000002","volume":"4","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, W\u00fcrbel H (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. BMJ Open Sci 4(1):e100115","journal-title":"BMJ Open Sci"},{"key":"10046_CR46","doi-asserted-by":"publisher","first-page":"1099554","DOI":"10.3389\/fnmol.2022.1099554","volume":"15","author":"RM Powers","year":"2022","unstructured":"Powers RM, Hevner RF, Halpain S (2022) The neuron navigators: structure, function, and evolutionary history. Front Mol Neurosci 15:1099554","journal-title":"Front Mol Neurosci"},{"key":"10046_CR47","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/ng1814","volume":"38","author":"MI Rees","year":"2006","unstructured":"Rees MI, Harvey K, Pearce BR, Chung SK, Duguid IC, Thomas P, Beatty S, Graham GE, Armstrong L, Shiang R, Abbott KJ, Zuberi SM, Stephenson JB, Owen MJ, Tijssen MA, van den Maagdenberg AM, Smart TG, Supplisson S, Harvey RJ (2006) Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat Genet 38:801\u2013806","journal-title":"Nat Genet"},{"key":"10046_CR48","doi-asserted-by":"publisher","first-page":"14172","DOI":"10.1038\/s41598-019-50627-w","volume":"9","author":"A Ricobaraza","year":"2019","unstructured":"Ricobaraza A, Mora-Jimenez L, Puerta E, Sanchez-Carpintero R, Mingorance A, Artieda J, Nicolas MJ, Besne G, Bunuales M, Gonzalez-Aparicio M, Sola-Sevilla N, Valencia M, Hernandez-Alcoceba R (2019) Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation. Sci Rep 9:14172","journal-title":"Sci Rep"},{"key":"10046_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nbd.2014.09.017","volume":"73","author":"M Rubinstein","year":"2015","unstructured":"Rubinstein M, Westenbroek RE, Yu FH, Jones CJ, Scheuer T, Catterall WA (2015) Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome. Neurobiol Dis 73:106\u2013117","journal-title":"Neurobiol Dis"},{"issue":"6228","key":"10046_CR50","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.aaa1299","volume":"347","author":"N Sada","year":"2015","unstructured":"Sada N, Lee S, Katsu T, Otsuki T, Inoue T (2015) Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy. Science (new York, N.y.) 347(6228):1362\u20131367","journal-title":"Science (new York, N.y.)"},{"key":"10046_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.02.058","volume":"1093","author":"H Sakagami","year":"2006","unstructured":"Sakagami H, Suzuki H, Kamata A, Owada Y, Fukunaga K, Mayanagi H, Kondo H (2006) Distinct spatiotemporal expression of EFA6D, a guanine nucleotide exchange factor for ARF6, among the EFA6 family in mouse brain. Brain Res 1093:1\u201311","journal-title":"Brain Res"},{"issue":"Suppl 2","key":"10046_CR52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1528-1167.2011.03002.x","volume":"52","author":"M Sakauchi","year":"2011","unstructured":"Sakauchi M, Oguni H, Kato I, Osawa M, Hirose S, Kaneko S, Takahashi Y, Takayama R, Fujiwara T (2011a) Mortality in Dravet syndrome: search for risk factors in Japanese patients. Epilepsia 52(Suppl 2):50\u201354","journal-title":"Epilepsia"},{"key":"10046_CR53","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1528-1167.2011.03053.x","volume":"52","author":"M Sakauchi","year":"2011","unstructured":"Sakauchi M, Oguni H, Kato I, Osawa M, Hirose S, Kaneko S, Takahashi Y, Takayama R, Fujiwara T (2011b) Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome. Epilepsia 52:1144\u20131149","journal-title":"Epilepsia"},{"key":"10046_CR54","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/epi4.12832","volume":"8","author":"A Strzelczyk","year":"2023","unstructured":"Strzelczyk A, Lagae L, Wilmshurst JM, Brunklaus A, Striano P, Rosenow F, Schubert-Bast S (2023) Dravet syndrome: a systematic literature review of the illness burden. Epilepsia Open 8:1256\u20131270","journal-title":"Epilepsia Open"},{"key":"10046_CR55","doi-asserted-by":"crossref","unstructured":"Vann NC, Pham FD, Dorst KE, Del Negro CA (2018) Dbx1 pre-B\u00f6tzinger complex interneurons comprise the core inspiratory oscillator for breathing in unanesthetized adult mice. eNeuro 5","DOI":"10.1101\/271585"},{"key":"10046_CR56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yebeh.2017.06.031","volume":"74","author":"N Villas","year":"2017","unstructured":"Villas N, Meskis MA, Goodliffe S (2017) Dravet syndrome: Characteristics, comorbidities, and caregiver concerns. Epilepsy & Behavior\u202f: E&b 74:81\u201386","journal-title":"Epilepsy & Behavior : E&b"},{"key":"10046_CR57","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/epi.17192","volume":"63","author":"JM Walters","year":"2022","unstructured":"Walters JM, Kim EC, Zhang J, Jeong HG, Bajaj A, Baculis BC, Tracy GC, Ibrahim B, Christian-Hinman CA, Llano DA, Huesmann GR, Chung HJ (2022) Pharmacological inhibition of STriatal-Enriched protein tyrosine Phosphatase by TC-2153 reduces hippocampal excitability and seizure propensity. Epilepsia 63:1211\u20131224","journal-title":"Epilepsia"},{"key":"10046_CR58","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/epi.17274","volume":"63","author":"EC Wirrell","year":"2022","unstructured":"Wirrell EC, Hood V, Knupp KG, Meskis MA, Nabbout R, Scheffer IE, Wilmshurst J, Sullivan J (2022) International consensus on diagnosis and management of Dravet syndrome. Epilepsia 63:1761\u20131777","journal-title":"Epilepsia"},{"key":"10046_CR59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.eplepsyres.2016.04.002","volume":"123","author":"G Xia","year":"2016","unstructured":"Xia G, Pourali SP, Warner TA, Zhang CQ, Macdonald RL, Kang JQ (2016) Altered GABAA receptor expression in brainstem nuclei and SUDEP in Gabrg2(+\/Q390X) mice associated with epileptic encephalopathy. Epilepsy Res 123:50\u201354","journal-title":"Epilepsy Res"},{"key":"10046_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12915-023-01704-0","volume":"21","author":"D Xie","year":"2023","unstructured":"Xie D, Gu B, Liu Y, Ye P, Ma Y, Wen T, Song X, Zhao Z (2023) Efficient targeted recombination with CRISPR\/Cas9 in hybrids of Caenorhabditis nematodes with suppressed recombination. BMC Biol 21:203","journal-title":"BMC Biol"},{"key":"10046_CR61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neulet.2011.03.008","volume":"494","author":"I Yordanova","year":"2011","unstructured":"Yordanova I, Todorov T, Dimova P, Hristova D, Tincheva R, Litvinenko I, Yotovska O, Kremensky I, Todorova A (2011) One novel Dravet syndrome causing mutation and one recurrent MAE causing mutation in SCN1A gene. Neurosci Lett 494:180\u2013183","journal-title":"Neurosci Lett"},{"key":"10046_CR62","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/nn1754","volume":"9","author":"FH Yu","year":"2006","unstructured":"Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, Spain WJ, McKnight GS, Scheuer T, Catterall WA (2006) Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 9:1142\u20131149","journal-title":"Nat Neurosci"},{"key":"10046_CR63","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.seizure.2010.06.010","volume":"19","author":"MJ Yu","year":"2010","unstructured":"Yu MJ, Shi YW, Gao MM, Deng WY, Liu XR, Chen L, Long YS, Yi YH, Liao WP (2010) Milder phenotype with SCN1A truncation mutation other than SMEI. Seizure 19:443\u2013445","journal-title":"Seizure"},{"key":"10046_CR64","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1212\/WNL.0b013e31820c309b","volume":"76","author":"SM Zuberi","year":"2011","unstructured":"Zuberi SM, Brunklaus A, Birch R, Reavey E, Duncan J, Forbes GH (2011) Genotype-phenotype associations in SCN1A-related epilepsies. Neurology 76:594\u2013600","journal-title":"Neurology"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-024-10046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-024-10046-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-024-10046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T02:03:57Z","timestamp":1723773837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-024-10046-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10046"],"URL":"https:\/\/doi.org\/10.1007\/s00335-024-10046-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.15.589561","asserted-by":"object"}]},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JAK serves on the Scientific Advisory Boards of the Dravet Syndrome Foundation and FamilieSCN2A Foundation. JAK receives research funding from Praxis Precision Medicines and Neurocrine Biosciences. NAH provides paid consulting services to Takeda Pharmaceuticals. All other authors have declared that no competing interests exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Animal care and experimental procedures were approved by the Northwestern University Animal Care and Use Committee in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}